57 results
Page 3 of 3
6-K
EX-99.1
mazkd1a0hma6sy6
5 Nov 20
Amryt Reports Record Q3 2020 Results - Raising FY 2020 Revenue Guidance
7:55am
6-K
EX-99.1
w1gf7e6ft9celaf2mh6
29 Oct 20
Amryt Announces Positive Results from Phase 3 Trial of Filsuvez® In Epidermolysis Bullosa
8:00am
6-K
EX-99.1
ps5hvbxcfgc2b4
6 Aug 20
Amryt Announces Q2 2020 Results and Issues Positive Revenue Guidance for Fy 2020
9:43am
424B4
djdnbt
8 Jul 20
Prospectus supplement with pricing info
4:05pm
F-1/A
737v63ouqf80vica
6 Jul 20
Registration statement (foreign) (amended)
5:28pm
F-1
EX-10.5
w2cbx
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.6
hgob1xlvgcv1h1auz
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.1
9vkj lxt3yxg
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.12.5
0u1xvddhcfbwbn25
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
u240hzx6d
23 Jun 20
Registration statement (foreign)
5:21pm
DRS/A
zn2w2ppz
29 May 20
Draft registration statement (amended)
12:00am
DRSLTR
wj8jk95 mpynng18
28 May 20
Correspondence regarding draft registration statement
12:00am
DRS/A
EX-10.12
4tllfef9
11 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.6
rifxe1l
11 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.5
15y92cxj1
11 May 20
Draft registration statement (amended)
12:00am
UPLOAD
gk7v vmlv3uwv3
19 Mar 20
Letter from SEC
12:00am
DRS
laxunolv50 zq
19 Feb 20
Draft registration statement
12:00am